Literature DB >> 35871425

How to establish infrastructures to achieve more efficient regenerative medicine?

Babak Arjmand1, Bagher Larijani2, Sepideh Alavi-Moghadam3, Hamid Reza Aghayan3, Mostafa Rezaei-Tavirani4, Parisa Goodarzi3, Akram Tayanloo-Beik3, Mahmood Biglar5, Mohsen Rajaeinejad6, Fatemeh Fazeli Shouroki3.   

Abstract

The field of regenerative medicine (RM) as an innovative technology has the ability to affect the healthcare system. It develops a variety of techniques through stem cell biology, genetics, bioengineering, biomaterial science, and tissue engineering to replace or restore the role of lost, disabled, or aging cells in the human body. However, the field's proficiency has still been underwhelming at the clinical trial level. This could be due to the innovation of such technologies, as well as their incredible nature. Therefore, managing the infrastructure framework for the safe and efficient application of the aforementioned field of science would help in the process of progress. In this context, the current review focuses on how to establish infrastructures for more effective RM.
© 2022. The Author(s), under exclusive licence to Springer Nature B.V.

Entities:  

Keywords:  Cell- and tissue-based therapy; Marketing of health services; Regenerative medicine

Year:  2022        PMID: 35871425     DOI: 10.1007/s10561-022-10028-2

Source DB:  PubMed          Journal:  Cell Tissue Bank        ISSN: 1389-9333            Impact factor:   1.752


  27 in total

Review 1.  Three-dimensional bioprinting in tissue engineering and regenerative medicine.

Authors:  Guifang Gao; Xiaofeng Cui
Journal:  Biotechnol Lett       Date:  2015-10-14       Impact factor: 2.461

Review 2.  Therapeutic abortion and ectopic pregnancy: alternative sources for fetal stem cell research and therapy in Iran as an Islamic country.

Authors:  Parisa Goodarzi; Khadijeh Falahzadeh; Hamidreza Aghayan; Moloud Payab; Bagher Larijani; Sepideh Alavi-Moghadam; Akram Tayanloo-Beik; Hossein Adibi; Kambiz Gilany; Babak Arjmand
Journal:  Cell Tissue Bank       Date:  2018-12-07       Impact factor: 1.522

Review 3.  Biological Products: Cellular Therapy and FDA Approved Products.

Authors:  Ali Golchin; Tahereh Zarnoosheh Farahany
Journal:  Stem Cell Rev Rep       Date:  2019-04       Impact factor: 5.739

4.  The social management of biomedical novelty: Facilitating translation in regenerative medicine.

Authors:  John Gardner; Andrew Webster
Journal:  Soc Sci Med       Date:  2016-03-18       Impact factor: 4.634

Review 5.  Concepts in regenerative medicine: Past, present, and future in articular cartilage treatment.

Authors:  Adam W Anz; Asawari Bapat; William D Murrell
Journal:  J Clin Orthop Trauma       Date:  2016-06-15

Review 6.  Personalized Regenerative Medicine.

Authors:  Babak Arjmand; Parisa Goodarzi; Fereshteh Mohamadi-Jahani; Khadijeh Falahzadeh; Bagher Larijani
Journal:  Acta Med Iran       Date:  2017-03

Review 7.  Development and validation of Alzheimer's Disease Animal Model for the Purpose of Regenerative Medicine.

Authors:  Parisa Goodarzi; Moloud Payab; Sepideh Alavi-Moghadam; Bagher Larijani; Fakher Rahim; Nikoo Bana; Masoumeh Sarvari; Hossein Adibi; Najmeh Foroughi Heravani; Mahdieh Hadavandkhani; Babak Arjmand
Journal:  Cell Tissue Bank       Date:  2019-05-13       Impact factor: 1.522

Review 8.  Cryopreservation of complex systems: the missing link in the regenerative medicine supply chain.

Authors:  Gregory M Fahy; Brian Wowk; Jun Wu
Journal:  Rejuvenation Res       Date:  2006       Impact factor: 4.663

Review 9.  Stem cell therapy for treatment of epilepsy.

Authors:  Parisa Goodarzi; Hamid Reza Aghayan; Masoud Soleimani; Abbas Norouzi-Javidan; Fereshteh Mohamadi-Jahani; Sharareh Jahangiri; Seyed Hasan Emami-Razavi; Bagher Larijani; Babak Arjmand
Journal:  Acta Med Iran       Date:  2014

Review 10.  Advances in Regenerative Medicine and Tissue Engineering: Innovation and Transformation of Medicine.

Authors:  Kevin Dzobo; Nicholas Ekow Thomford; Dimakatso Alice Senthebane; Hendrina Shipanga; Arielle Rowe; Collet Dandara; Michael Pillay; Keolebogile Shirley Caroline M Motaung
Journal:  Stem Cells Int       Date:  2018-07-30       Impact factor: 5.443

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.